Quantcast

Latest Debiopharm Group Stories

2011-07-26 02:00:00

LAUSANNE, Switzerland and RALEIGH, North Carolina, July 26, 2011 /PRNewswire/ -- INC Research, LLC, a therapeutically focused contract research organisation (CRO) with a trusted process for delivering reliable results, and Debiopharm Group(TM) ("Debiopharm"), a Swiss-based global biopharmaceutical group with a focus on drug development and companion diagnostics, today announced a strategic partnership.

2011-07-14 03:45:00

LAUSANNE, Switzerland, July 14, 2011 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative therapies, primarily in oncology, has appointed a number of management figures to key positions, which will help ensure the perennial success of the group over the long term. Although Debiopharm is a private company, it is committed to ensure the same level of financial rigor and...

2011-05-04 02:00:00

LAUSANNE, Switzerland and NEW HAVEN, Connecticut, May 4, 2011 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Yale University (Yale), a premier university with a long tradition of both basic and clinically directed biomedical research, announce an exclusive worldwide license agreement concerning the development and commercialization of Debio 1036, a first-in-class...

2011-04-14 02:00:00

LAUSANNE, Switzerland and BANGALORE, India, April 14, 2011 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Aurigene Discovery Technologies Ltd (Aurigene), a Bangalore-based drug discovery company, signed on March 23, 2011 an option and exclusive worldwide license agreement concerning the development and commercialisation of Debio 1142, a novel inhibitor of an...

2011-01-18 02:00:00

LAUSANNE, Switzerland, January 18, 2011 /PRNewswire/ -- Diagnoplex SA, a developer of molecular diagnostics for colon cancer and Debiopharm Group(TM) announced today that Diagnoplex has closed a series A financing extension with Debiopharm Group(TM).

2010-12-01 09:00:00

LAUSANNE, Switzerland, December 1, 2010 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, today announced that it received the "2010 Frost & Sullivan European Biopharmaceuticals Company of the Year Award".

2010-11-23 08:00:00

LAUSANNE, Switzerland, November 23, 2010 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), an independent specialist in global bio-pharmaceutical development in the field of oncology and regarding certain serious diseases, has announced the winner of the Prix Debiopharm Valais pour les Sciences de la Vie (Debiopharm Valais Life Sciences Prize).


Word of the Day
edulcoration
  • The act of sweetening by admixture of some saccharine substance.
The word 'edulcoration' comes from a Latin word meaning 'making sweet'.